Orbimed Advisors as of June 30, 2019
Portfolio Holdings for Orbimed Advisors
Orbimed Advisors holds 123 positions in its portfolio as reported in the June 2019 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Ascendis Pharma A S (ASND) | 6.9 | $443M | 3.8M | 115.15 | |
| Tricida | 6.8 | $439M | 11M | 39.46 | |
| Boston Scientific Corporation (BSX) | 4.5 | $290M | 6.8M | 42.98 | |
| Alexion Pharmaceuticals | 3.9 | $252M | 1.9M | 130.98 | |
| Alector (ALEC) | 3.9 | $251M | 13M | 19.00 | |
| Merck & Co (MRK) | 3.3 | $216M | 2.6M | 83.85 | |
| Prevail Therapeutics Ord | 2.8 | $183M | 14M | 13.20 | |
| Vertex Pharmaceuticals Incorporated (VRTX) | 2.8 | $179M | 973k | 183.38 | |
| Neurocrine Biosciences (NBIX) | 2.4 | $155M | 1.8M | 84.43 | |
| Iovance Biotherapeutics (IOVA) | 2.1 | $136M | 5.5M | 24.52 | |
| Thermo Fisher Scientific (TMO) | 2.1 | $136M | 463k | 293.68 | |
| Edwards Lifesciences (EW) | 2.0 | $132M | 715k | 184.74 | |
| Sarepta Therapeutics (SRPT) | 1.9 | $126M | 828k | 151.95 | |
| Wright Medical Group Nv | 1.9 | $125M | 4.2M | 29.82 | |
| Intuitive Surgical (ISRG) | 1.7 | $110M | 210k | 524.55 | |
| Turning Point Therapeutics I | 1.6 | $105M | 2.6M | 40.70 | |
| Anthem (ELV) | 1.6 | $102M | 362k | 282.21 | |
| Ptc Therapeutics I (PTCT) | 1.5 | $94M | 2.1M | 45.00 | |
| Bausch Health Companies (BHC) | 1.5 | $94M | 3.7M | 25.22 | |
| Natera (NTRA) | 1.4 | $89M | 3.2M | 27.58 | |
| Inspire Med Sys (INSP) | 1.4 | $89M | 1.5M | 60.65 | |
| Bristol Myers Squibb (BMY) | 1.3 | $84M | 1.8M | 45.35 | |
| Exelixis (EXEL) | 1.3 | $84M | 3.9M | 21.37 | |
| Logicbio Therapeutics | 1.3 | $84M | 6.5M | 13.00 | |
| Avedro | 1.3 | $83M | 4.2M | 19.64 | |
| Deciphera Pharmaceuticals (DCPH) | 1.3 | $82M | 3.6M | 22.55 | |
| Abbott Laboratories (ABT) | 1.2 | $79M | 938k | 84.10 | |
| eHealth (EHTH) | 1.2 | $78M | 910k | 86.10 | |
| Athenex | 1.2 | $76M | 3.8M | 19.80 | |
| Synthorx | 1.1 | $72M | 5.3M | 13.51 | |
| Uniqure Nv (QURE) | 1.1 | $70M | 898k | 78.15 | |
| Meiragtx Holdings (MGTX) | 1.1 | $70M | 2.6M | 26.88 | |
| Regeneron Pharmaceuticals (REGN) | 1.1 | $68M | 216k | 313.00 | |
| Agilent Technologies Inc C ommon (A) | 1.0 | $67M | 893k | 74.67 | |
| Audentes Therapeutics | 1.0 | $65M | 1.7M | 37.86 | |
| Arvinas Ord (ARVN) | 0.9 | $59M | 2.7M | 21.99 | |
| Principia Biopharma | 0.8 | $53M | 1.6M | 33.19 | |
| Illumina (ILMN) | 0.8 | $52M | 140k | 368.15 | |
| Crinetics Pharmaceuticals In (CRNX) | 0.8 | $51M | 2.0M | 25.00 | |
| Restorbio | 0.8 | $49M | 4.8M | 10.20 | |
| Apellis Pharmaceuticals (APLS) | 0.8 | $48M | 1.9M | 25.34 | |
| Myokardia | 0.7 | $48M | 955k | 50.14 | |
| Viewray (VRAYQ) | 0.7 | $45M | 5.1M | 8.81 | |
| Argenx Se (ARGX) | 0.7 | $44M | 310k | 141.58 | |
| Zai Lab (ZLAB) | 0.6 | $41M | 1.2M | 34.87 | |
| Nextcure (NXTC) | 0.6 | $41M | 2.7M | 14.98 | |
| Cigna Corp (CI) | 0.6 | $40M | 253k | 157.55 | |
| Dex (DXCM) | 0.6 | $39M | 263k | 149.84 | |
| Tandem Diabetes Care (TNDM) | 0.6 | $37M | 571k | 64.52 | |
| Gilead Sciences (GILD) | 0.5 | $34M | 502k | 67.56 | |
| Prothena (PRTA) | 0.5 | $32M | 3.1M | 10.57 | |
| Harpoon Therapeutics | 0.5 | $32M | 2.4M | 13.00 | |
| Takeda Pharmaceutical (TAK) | 0.5 | $31M | 1.8M | 17.70 | |
| Caredx (CDNA) | 0.5 | $30M | 828k | 35.99 | |
| Obseva Sa | 0.5 | $30M | 2.6M | 11.31 | |
| Spdr S&p 500 Etf (SPY) | 0.5 | $29M | 100k | 293.00 | |
| Clovis Oncology | 0.4 | $28M | 1.9M | 14.87 | |
| Xtant Med Hldgs (XTNT) | 0.4 | $28M | 9.2M | 3.00 | |
| Mylan Nv | 0.4 | $26M | 1.4M | 19.04 | |
| Krystal Biotech (KRYS) | 0.4 | $26M | 642k | 40.27 | |
| Endo International (ENDPQ) | 0.4 | $25M | 6.2M | 4.12 | |
| Corvus Pharmaceuticals (CRVS) | 0.4 | $25M | 6.6M | 3.74 | |
| Aurinia Pharmaceuticals (AUPH) | 0.4 | $23M | 3.5M | 6.58 | |
| Adverum Biotechnologies | 0.4 | $23M | 2.0M | 11.89 | |
| Amgen (AMGN) | 0.3 | $23M | 122k | 184.28 | |
| Spark Therapeutics | 0.3 | $23M | 220k | 102.38 | |
| Kala Pharmaceuticals | 0.3 | $22M | 3.4M | 6.38 | |
| Genfit S A ads (GNFT) | 0.3 | $22M | 1.1M | 19.75 | |
| Alcon (ALC) | 0.3 | $22M | 351k | 61.71 | |
| Biogen Idec (BIIB) | 0.3 | $21M | 88k | 233.87 | |
| Si-bone (SIBN) | 0.3 | $20M | 985k | 20.34 | |
| Karyopharm Therapeutics (KPTI) | 0.3 | $19M | 3.1M | 5.99 | |
| Synlogic | 0.3 | $19M | 2.0M | 9.10 | |
| Rhythm Pharmaceuticals (RYTM) | 0.3 | $17M | 787k | 22.00 | |
| Verrica Pharmaceuticals (VRCA) | 0.3 | $17M | 1.5M | 11.62 | |
| Novo Nordisk A/S (NVO) | 0.3 | $17M | 330k | 51.04 | |
| Sinovac Biotech (SVA) | 0.3 | $17M | 2.8M | 5.85 | |
| Alpine Immune Sciences (ALPN) | 0.2 | $16M | 3.7M | 4.21 | |
| Abbvie (ABBV) | 0.2 | $15M | 200k | 72.72 | |
| Aeglea Biotherapeutics | 0.2 | $15M | 2.2M | 6.85 | |
| Amarin Corporation (AMRN) | 0.2 | $14M | 718k | 19.39 | |
| X4 Pharmaceuticals (XFOR) | 0.2 | $14M | 937k | 15.00 | |
| BioMarin Pharmaceutical (BMRN) | 0.2 | $13M | 150k | 85.65 | |
| Proqr Thrapeutics N V shs euro (PRQR) | 0.2 | $13M | 1.4M | 9.10 | |
| Foamix Pharmaceuticals | 0.2 | $12M | 5.2M | 2.38 | |
| Immunomedics | 0.2 | $11M | 818k | 13.87 | |
| Pfizer (PFE) | 0.2 | $11M | 250k | 43.32 | |
| Stryker Corporation (SYK) | 0.2 | $11M | 54k | 205.57 | |
| ArQule | 0.2 | $11M | 1.0M | 11.01 | |
| Nabriva Therapeutics | 0.2 | $11M | 4.6M | 2.43 | |
| Scpharmaceuticals (SCPH) | 0.2 | $11M | 3.4M | 3.19 | |
| Constellation Pharmceticls I | 0.2 | $10M | 836k | 12.28 | |
| Reata Pharmaceuticals Inc Cl A | 0.1 | $9.4M | 100k | 94.35 | |
| Personalis Ord (PSNL) | 0.1 | $8.1M | 300k | 27.15 | |
| Puma Biotechnology (PBYI) | 0.1 | $7.9M | 624k | 12.71 | |
| Mersana Therapeutics (MRSN) | 0.1 | $7.7M | 1.9M | 4.05 | |
| Assembly Biosciences | 0.1 | $7.1M | 524k | 13.49 | |
| Amicus Therapeutics (FOLD) | 0.1 | $6.5M | 518k | 12.48 | |
| Xenon Pharmaceuticals (XENE) | 0.1 | $6.3M | 635k | 9.86 | |
| Arena Pharmaceuticals | 0.1 | $6.4M | 110k | 58.63 | |
| Verona Pharma Plc ads (VRNA) | 0.1 | $6.4M | 1.3M | 5.10 | |
| Medicines Company | 0.1 | $5.5M | 152k | 36.47 | |
| Spero Therapeutics (SPRO) | 0.1 | $5.8M | 508k | 11.51 | |
| Adaptive Biotechnologies Cor (ADPT) | 0.1 | $5.8M | 120k | 48.30 | |
| Ultragenyx Pharmaceutical (RARE) | 0.1 | $5.1M | 80k | 63.50 | |
| Adaptimmune Therapeutics (ADAP) | 0.1 | $5.4M | 1.4M | 4.02 | |
| Intellia Therapeutics (NTLA) | 0.1 | $5.4M | 328k | 16.37 | |
| Selecta Biosciences (RNAC) | 0.1 | $5.2M | 2.9M | 1.79 | |
| Cti Biopharma | 0.1 | $4.3M | 5.0M | 0.86 | |
| Aerpio Pharmaceuticals | 0.1 | $4.7M | 5.2M | 0.91 | |
| Menlo Therapeutics | 0.1 | $4.0M | 674k | 5.99 | |
| Stoke Therapeutics (STOK) | 0.1 | $3.8M | 130k | 29.17 | |
| Novus Therapeutics | 0.1 | $3.2M | 3.2M | 1.01 | |
| ACADIA Pharmaceuticals (ACAD) | 0.0 | $2.7M | 102k | 26.73 | |
| Dynavax Technologies (DVAX) | 0.0 | $2.3M | 584k | 3.99 | |
| Realm Therapeutics | 0.0 | $2.9M | 1.0M | 2.81 | |
| Marinus Pharmaceuticals | 0.0 | $1.7M | 398k | 4.15 | |
| Syndax Pharmaceuticals (SNDX) | 0.0 | $2.0M | 212k | 9.31 | |
| Avrobio Ord (AVRO) | 0.0 | $1.7M | 106k | 16.26 | |
| Flexion Therapeutics | 0.0 | $1.1M | 90k | 12.30 | |
| Nuvectra | 0.0 | $1.2M | 350k | 3.35 | |
| Biolinerx Ltd-spons | 0.0 | $374k | 1.0M | 0.36 | |
| Medigus | 0.0 | $37k | 15k | 2.47 |
